Skip to main content
. Author manuscript; available in PMC: 2007 Jul 9.
Published in final edited form as: J Comp Neurol. 2005 Mar 21;483(4):458–475. doi: 10.1002/cne.20437

TABLE 2.

Synaptophysin Immunostaining in AVCN, PVCN, and DCN in Control (N = 3) and Ablated (N = 8) Animals1

Left side (contralateral)
Right side (ipsilateral)
Nucleus
mean gray
level
Immunostained
area (% relative
to the entire field)
Mean number
of boutons
Nucleus mean
gray level
Immunostained
area (% relative
to the entire field)
Mean number
of boutons
Control
AVCN 93.50 ± 10.15 3.42 ± 0.58 418.44 ± 17.40 96.99 ± 8.04   3.41 ± 0.46(**) 409.02 ± 26.88(**)
PVCN 86.12 ± 12.26 3.98 ± 0.40 416.31 ± 69.61 88.17 ± 19.56   3.99 ± 0.51(**) 413.75 ± 66.87(**)
DCN 97.01 ± 8.52 4.12 ± 0.17 449.64 ± 30.29 99.43 ± 4.29   4.12 ± 0.31 447.36 ± 26.60
Ablated
AVCN2 96.14 ± 16.37  3.51 ± 0.09(*) 415.93 ± 48.14(*) 92.00 ± 11.84   3.60 ± 0.33 529.02 ± 104.83(*)(**)
3   2.28 ± 0.31(*)(**) 354.44 ± 70.23
PVCN2 96.37 ± 11.68  3.62 ± 0.59(*) 390.24 ± 49.74(*) 98.79 ± 5.71   3.62 ± 0.12 550.29 ± 65.82(*)(**)
3   2.78 ± 0.09(*)(**) 374.00 ± 89.24
DCN 87.78 ± 9.04 4.04 ± 0.45 452.21 ± 22.32 91.07 ± 6.21   3.86 ± 0.15 450.70 ± 2.40
1

Values expressed are means and standard deviations.

2

Not corrected values.

3

Corrected values.

(*)

indicates significant differences between sides

(**)

indicates significant differences between groups; AVCN, anteroventral; DCN, dorsal cochlear nucleus; PVCN, posteroventral.